461 related articles for article (PubMed ID: 3641694)
21. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
Densen P; McRill CM; Ross SC
J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
[TBL] [Abstract][Full Text] [Related]
22. [Mechanisms of action and clinical importance of C3-nephritic-factor (author's transl)].
Lanzer G; Pogglitsch H; Tilz GP
Acta Med Austriaca; 1981; 8(1):7-13. PubMed ID: 6908995
[TBL] [Abstract][Full Text] [Related]
23. Partial lipodystrophy and glomerulonephritis without complement activation.
Mery JP; Kourilsky O; Morel-Maroger L; Adam C
N Engl J Med; 1978 May; 298(18):1034. PubMed ID: 643001
[No Abstract] [Full Text] [Related]
24. Terminal complement complex in plasma from patients with systemic lupus erythematosus and other glomerular diseases.
Horigome I; Seino J; Sudo K; Kinoshita Y; Saito T; Yoshinaga K
Clin Exp Immunol; 1987 Nov; 70(2):417-24. PubMed ID: 3427827
[TBL] [Abstract][Full Text] [Related]
25. A hemolytic method for the measurement of nephritic factor.
West CD
J Immunol Methods; 2008 Jun; 335(1-2):1-7. PubMed ID: 18410942
[TBL] [Abstract][Full Text] [Related]
26. Relationship between the component and regulatory proteins of the classical pathway C3 convertase.
Welch TR; Forristal J; Beischel L
J Lab Clin Med; 1986 Jun; 107(6):529-33. PubMed ID: 3635565
[TBL] [Abstract][Full Text] [Related]
27. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
[TBL] [Abstract][Full Text] [Related]
28. Modulation of complement by autoimmune antibodies isolated from sera of patients with membranoproliferative glomerulonephritis and systemic lupus erythematosus.
Daha MR; Van Es LA
Neth J Med; 1982; 25(7):202-7. PubMed ID: 6924073
[No Abstract] [Full Text] [Related]
29. [Proteases in complement system (author's transl)].
Nagasawa S
Tanpakushitsu Kakusan Koso; 1980; 25(6):531-46. PubMed ID: 7010425
[No Abstract] [Full Text] [Related]
30. Activation of the classic complement pathway in patients with the C3 nephritic factor.
McLean RH; Siegel NJ; Kashgarian M
Nephron; 1980; 25(2):57-64. PubMed ID: 6986570
[TBL] [Abstract][Full Text] [Related]
31. Structure and molecular genetics of complement proteins. An update.
Volanakis JE
Year Immunol; 1986; 2():164-76. PubMed ID: 3554821
[No Abstract] [Full Text] [Related]
32. C3 nephritic factor and hypocomplementaemia in a clinically healthy individual.
Gewurz AT; Imherr SM; Strauss S; Gewurz H; Mold C
Clin Exp Immunol; 1983 Oct; 54(1):253-8. PubMed ID: 6616970
[TBL] [Abstract][Full Text] [Related]
33. [Production of C3 nephritic factor by cultured lymphocytes derived from glomerulonephritic patients].
Yamada A; Ohi H; Hatano M
Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):373-8. PubMed ID: 2376910
[TBL] [Abstract][Full Text] [Related]
34. The role of carbohydrate in the structure and function of nephritic factor.
Scott DM; Amos N; Bartolotti SR
Clin Exp Immunol; 1981 Oct; 46(1):120-9. PubMed ID: 6802534
[TBL] [Abstract][Full Text] [Related]
35. Modulation of the activity of the classical complement pathway C3 convertase by surface-bound C3 or C5.
Strunk RC; Giclas PC
J Immunol; 1980 Feb; 124(2):520-6. PubMed ID: 7356706
[No Abstract] [Full Text] [Related]
36. A case of hypocomplementemic mesangiocapillary glomerulonephritis: appearance of C3 NeF and another factor.
Seki M; Ohi H; Watanabe S; Kojima H; Fujita T; Hatano M
Nihon Jinzo Gakkai Shi; 1987 May; 29(5):585-8. PubMed ID: 3656714
[No Abstract] [Full Text] [Related]
37. [Chronic urticaria and acquired complement deficiency due to a nephritic factor (C3NeF)].
Borradori L; Rybojad M; Weiss L; Späth P; Puissant A; Morel P
Schweiz Med Wochenschr; 1990 Aug; 120(34):1236-41. PubMed ID: 2218445
[TBL] [Abstract][Full Text] [Related]
38. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
Mirapeix E; Yagüe J; Vives J; Revert L
Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
Gigli I; Sorvillo J; Mecarelli-Halbwachs L; Leibowitch J
J Exp Med; 1981 Jul; 154(1):1-12. PubMed ID: 7019379
[TBL] [Abstract][Full Text] [Related]
40. [Direct detection C3bBb stabilizing activity in sera from hypocomplementaemic membranoproliferative glomerulonephritis (MPGN) and complement profiles of C3NeF positive cases].
Watanabe S; Ohi H; Seki M; Fujita T; Hatano M
Nihon Jinzo Gakkai Shi; 1985 Oct; 27(10):1345-52. PubMed ID: 4094159
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]